Stone House Investment Management, LLC Crispr Therapeutics Ag Transaction History
Stone House Investment Management, LLC
- $421 Million
- Q1 2024
A detailed history of Stone House Investment Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Stone House Investment Management, LLC holds 569 shares of CRSP stock, worth $31,044. This represents 0.01% of its overall portfolio holdings.
Number of Shares
569
Previous 169
236.69%
Holding current value
$31,044
Previous $10,000
280.0%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRSP
# of Institutions
547Shares Held
56.2MCall Options Held
2.91MPut Options Held
2.47M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.16MShares$445 Million3.97% of portfolio
-
Capital International Investors Los Angeles, CA7.84MShares$428 Million0.11% of portfolio
-
Nikko Asset Management Americas, Inc.3.27MShares$178 Million2.23% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$172 Million0.13% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.7MShares$148 Million0.11% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.26B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....